Free Trial

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $43.73 Million Stock Holdings in Amdocs Limited $DOX

Amdocs logo with Computer and Technology background

Key Points

  • UBS Asset Management increased its stake in Amdocs Limited by 3.9%, now owning 477,898 shares worth approximately $43.73 million.
  • Amdocs recently reported earnings of $1.72 per share, which surpassed analyst expectations, while also experiencing an 8.4% year-over-year decline in revenue.
  • The company announced a quarterly dividend of $0.527 per share, which will be paid on October 31st, representing a 2.5% dividend yield.
  • Five stocks to consider instead of Amdocs.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 3.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 477,898 shares of the technology company's stock after purchasing an additional 18,068 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned 0.42% of Amdocs worth $43,728,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in DOX. OneDigital Investment Advisors LLC boosted its position in Amdocs by 20.8% in the first quarter. OneDigital Investment Advisors LLC now owns 3,026 shares of the technology company's stock valued at $277,000 after buying an additional 521 shares during the last quarter. Farther Finance Advisors LLC raised its stake in Amdocs by 17.5% in the 1st quarter. Farther Finance Advisors LLC now owns 988 shares of the technology company's stock valued at $90,000 after purchasing an additional 147 shares during the last quarter. Cambridge Investment Research Advisors Inc. grew its holdings in Amdocs by 7.8% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 6,738 shares of the technology company's stock valued at $616,000 after buying an additional 490 shares in the last quarter. Ritholtz Wealth Management grew its holdings in shares of Amdocs by 18.9% during the 1st quarter. Ritholtz Wealth Management now owns 3,195 shares of the technology company's stock worth $292,000 after purchasing an additional 507 shares during the period. Finally, Norden Group LLC increased its position in shares of Amdocs by 26.9% during the 1st quarter. Norden Group LLC now owns 3,978 shares of the technology company's stock worth $364,000 after purchasing an additional 843 shares during the last quarter. Hedge funds and other institutional investors own 92.02% of the company's stock.

Amdocs Stock Performance

Shares of Amdocs stock traded down $0.70 on Friday, reaching $83.79. 1,066,788 shares of the company were exchanged, compared to its average volume of 766,165. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.22 and a current ratio of 1.22. The company's 50-day moving average is $86.52 and its two-hundred day moving average is $88.43. The firm has a market cap of $9.46 billion, a price-to-earnings ratio of 17.00, a P/E/G ratio of 1.54 and a beta of 0.54. Amdocs Limited has a 1-year low of $78.61 and a 1-year high of $95.41.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its earnings results on Wednesday, August 6th. The technology company reported $1.72 EPS for the quarter, beating the consensus estimate of $1.71 by $0.01. The firm had revenue of $1.14 billion for the quarter, compared to analysts' expectations of $1.13 billion. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm's revenue was down 8.4% compared to the same quarter last year. During the same period last year, the firm earned $1.62 EPS. As a group, research analysts expect that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a dividend of $0.527 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $2.11 dividend on an annualized basis and a yield of 2.5%. Amdocs's dividend payout ratio (DPR) is 42.80%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on DOX. Wall Street Zen raised Amdocs from a "hold" rating to a "buy" rating in a research report on Sunday, August 10th. Wolfe Research began coverage on Amdocs in a report on Tuesday, July 8th. They issued an "outperform" rating on the stock. Four research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company has an average rating of "Buy" and an average price target of $105.33.

Read Our Latest Report on DOX

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Stories

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.